Sai Life Sciences’ ₹3,042 crore IPO opens today, closing December 13. The offer includes a fresh issue and an OFS, aiming to repay debt. Priced at ₹522-549 per share, analysts advise caution due to high valuation and OFS-heavy structure, despite strong financial performance.
Crompton Greaves, Delhivery among 10 mid-cap stocks analysts expect to rally up to 53%
Oil India is also rated 5 on average by 10 analysts. The average target price is Rs 647, showing a 53% upside potential from the